Aerpio Pharmaceuticals, Inc Earning Date (ARPO)

USA |NASDAQ |USD

ARPO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 9, 2022 Dec 2021 - - $-0.11
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 9, 2022 Dec 2021 - - $0.02

Aerpio Pharmaceuticals, Inc's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 2021.

ARPO Earnings Date & History Chart

ARPO Earnings & Revenue Forecast

ARPO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 0 $0.00 $0.00 $0.00

ARPO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.82 $-0.39 $-0.39

ARPO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $2.87M $2.87M $2.87M

ARPO Earnings Date & Revenue History

ARPO Earnings History

|
Show More
Show More

ARPO Revenue History

|
Show More
Show More

Aerpio Pharmaceuticals, Inc Next Earnings Date & Report

ARPO Next Earnings Date & Report Preview: Dec 2021 (FQ)

ARPO's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 31, 2021.

Aerpio Pharmaceuticals, Inc Previous Earnings Dates & Reports

ARPO Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Aerpio Pharmaceuticals, Inc's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

ARPO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aerpio Pharmaceuticals, Inc's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

ARPO's earnings per share (EPS) was $-0.10, beating the consensus analysts forecast of $-0.14 by -28.57% , and higher than the previous year's EPS (Dec 2019) by -81.06%.

Revenues were $15.00M.

The company reported a net income of $-4.32M.

Aerpio Pharmaceuticals, Inc reported a free cash flow of $-5.40M for its fiscal year, compared to $-24.09M a year ago.

The company ended the fiscal year with $67.44K in total debt, a decrease of -60.33% compared to the previous year.